Insulin-like growth factor-I and prostate cancer: a meta-analysis
GLP-1s): Multi-dose vials (e.g
Enhancers must balance efficacy against safety, since indiscriminately loosening the gut barrier is undesirable
Chronic toxicity, carcinogenicity, endocrine disruption, and long-term organ impact have not been systematically studied in the BPC-157 literature
Some protocols begin with a brief intensive phase (for example, daily or alternate-day dosing) followed by a maintenance phase (for example, weekly to monthly), particularly for B12 deficiency
What science exists for GHK-Cu is all rather positive (a 2018 analysis of the science concluded the peptides actions appear to be health positive, saying it boosts collagen, improves tissue repair and has powerful cell-protective actions, including multiple anti-cancer and anti-inflammatory actions)